| - GRCh37:
- Chr13:103506164
- GRCh38:
- Chr13:102853814
| BIVM-ERCC5, ERCC5 | K108fs, K562fs | Xeroderma pigmentosum, group G | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr13:103518244
- GRCh38:
- Chr13:102865894
| BIVM-ERCC5, ERCC5, LOC126861834 | W1182R, W728R | Xeroderma pigmentosum, group G | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr13:103506636
- GRCh38:
- Chr13:102854286
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr13:103506225
- GRCh38:
- Chr13:102853875
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G | Uncertain significance (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103513855
- GRCh38:
- Chr13:102861505
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G, Cerebrooculofacioskeletal syndrome 3, not provided
| Pathogenic/Likely pathogenic (Oct 4, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103514538
- GRCh38:
- Chr13:102862188
| BIVM-ERCC5, ERCC5 | A347S, A801S | not provided, Xeroderma pigmentosum, group G, Cerebrooculofacioskeletal syndrome 3
| Uncertain significance (Aug 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103519054
- GRCh38:
- Chr13:102866704
| BIVM-ERCC5, ERCC5, LOC126861834 | D1252Y, D798Y | not provided | Uncertain significance (Jun 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103528246
- GRCh38:
- Chr13:102875896
| BIVM-ERCC5, ERCC5 | K1185T, K1639T | Cerebrooculofacioskeletal syndrome 3, Cerebrooculofacioskeletal syndrome 3, Xeroderma pigmentosum, group G, Hereditary cancer-predisposing syndrome, not provided | Uncertain significance (May 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103528130
- GRCh38:
- Chr13:102875780
| BIVM-ERCC5, ERCC5 | S1146R, S1600R | Cerebrooculofacioskeletal syndrome 3, Xeroderma pigmentosum, group G | Uncertain significance (Jun 23, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103528113
- GRCh38:
- Chr13:102875763
| BIVM-ERCC5, ERCC5 | G1141R, G1595R | Xeroderma pigmentosum, group G | Uncertain significance (Feb 2, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103519117
- GRCh38:
- Chr13:102866767
| BIVM-ERCC5, ERCC5, LOC126861834 | R819W, R1273W | Xeroderma pigmentosum, group G, Cerebrooculofacioskeletal syndrome 3, Xeroderma pigmentosum, group G
| Uncertain significance (Feb 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103519045
- GRCh38:
- Chr13:102866695
| LOC126861834, BIVM-ERCC5, ERCC5 | A1249T, A795T | Xeroderma pigmentosum, group G, not specified, not provided
| Uncertain significance (Nov 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103518660
- GRCh38:
- Chr13:102866310
| BIVM-ERCC5, ERCC5, LOC126861834 | | Xeroderma pigmentosum, group G | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103514542
- GRCh38:
- Chr13:102862192
| ERCC5, BIVM-ERCC5 | M802R, M348R | Xeroderma pigmentosum, group G | Uncertain significance (Mar 23, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103514529
- GRCh38:
- Chr13:102862179
| BIVM-ERCC5, ERCC5 | T344A, T798A | Hereditary cancer-predisposing syndrome, Xeroderma pigmentosum, group G | Uncertain significance (Jan 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103514431
- GRCh38:
- Chr13:102862081
| BIVM-ERCC5, ERCC5 | S765C, S311C | Hereditary cancer-predisposing syndrome, not provided, Inborn genetic diseases, Xeroderma pigmentosum, group G | Uncertain significance (Jun 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103498471
- GRCh38:
- Chr13:102846121
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103498425
- GRCh38:
- Chr13:102846075
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103528103
- GRCh38:
- Chr13:102875753
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103527944
- GRCh38:
- Chr13:102875594
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103518253
- GRCh38:
- Chr13:102865903
| BIVM-ERCC5, ERCC5, LOC126861834 | I1185F, I731F | Xeroderma pigmentosum, group G | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103518011
- GRCh38:
- Chr13:102865661
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G | Uncertain significance (Jan 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103515458
- GRCh38:
- Chr13:102863108
| BIVM-ERCC5, ERCC5 | | not provided, Xeroderma pigmentosum, group G | Uncertain significance (May 6, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103510760
- GRCh38:
- Chr13:102858410
| BIVM-ERCC5, ERCC5 | M676V, M222V | Hereditary cancer-predisposing syndrome, Xeroderma pigmentosum, group G | Uncertain significance (Jul 9, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103498237
- GRCh38:
- Chr13:102845887
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103508413
- GRCh38:
- Chr13:102856063
| BIVM-ERCC5, ERCC5 | E614V, E160V | Xeroderma pigmentosum, group G | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103506135
- GRCh38:
- Chr13:102853785
| BIVM-ERCC5, ERCC5 | A98V, A552V | Xeroderma pigmentosum, group G, Cerebrooculofacioskeletal syndrome 3, Xeroderma pigmentosum, group G
| Uncertain significance (Dec 9, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103515270
- GRCh38:
- Chr13:102862920
| BIVM-ERCC5, ERCC5 | S1045R, S591R | Xeroderma pigmentosum, group G | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103514997
- GRCh38:
- Chr13:102862647
| BIVM-ERCC5, ERCC5 | R954W, R500W | Xeroderma pigmentosum, group G, Inborn genetic diseases | Uncertain significance (Jul 30, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103528341
- GRCh38:
- Chr13:102875991
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G | Uncertain significance (Mar 30, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103528225
- GRCh38:
- Chr13:102875875
| BIVM-ERCC5, ERCC5 | R1632H, R1178H | Xeroderma pigmentosum, group G, Ovarian cancer | Conflicting interpretations of pathogenicity (Jan 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103524625
- GRCh38:
- Chr13:102872275
| BIVM-ERCC5, ERCC5 | R1373Q, R919Q | Xeroderma pigmentosum, group G | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103520533
- GRCh38:
- Chr13:102868183
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103514631
- GRCh38:
- Chr13:102862281
| BIVM-ERCC5, ERCC5 | V378I, V832I | Xeroderma pigmentosum, group G | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103504625
- GRCh38:
- Chr13:102852275
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103504458
- GRCh38:
- Chr13:102852108
| BIVM-ERCC5, ERCC5 | | not provided, Xeroderma pigmentosum, group G | Uncertain significance (Jul 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103498692
- GRCh38:
- Chr13:102846342
| BIVM-ERCC5, ERCC5 | I26V | Hereditary cancer-predisposing syndrome, Xeroderma pigmentosum, group G | Likely benign (Dec 21, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103498648
- GRCh38:
- Chr13:102846298
| ERCC5, BIVM-ERCC5 | E11A | Xeroderma pigmentosum, group G | Uncertain significance (Jan 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103515286
- GRCh38:
- Chr13:102862936
| BIVM-ERCC5, ERCC5 | A1050G, A596G | Xeroderma pigmentosum, group G | Uncertain significance (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103515267
- GRCh38:
- Chr13:102862917
| BIVM-ERCC5, ERCC5 | V1044I, V590I | Hereditary cancer-predisposing syndrome, not provided, Cerebrooculofacioskeletal syndrome 3, Xeroderma pigmentosum, group G | Conflicting interpretations of pathogenicity (Aug 25, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103514020-103514021
- GRCh38:
- Chr13:102861670-102861671
| BIVM-ERCC5, ERCC5 | V281fs, V735fs | Xeroderma pigmentosum, group G | Pathogenic (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103518692
- GRCh38:
- Chr13:102866342
| BIVM-ERCC5, ERCC5, LOC126861834 | | not provided, Xeroderma pigmentosum, group G | Conflicting interpretations of pathogenicity (Sep 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103506136
- GRCh38:
- Chr13:102853786
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G, not provided | Conflicting interpretations of pathogenicity (Apr 26, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103519119
- GRCh38:
- Chr13:102866769
| BIVM-ERCC5, ERCC5, LOC126861834 | | not provided, Xeroderma pigmentosum, group G | Benign/Likely benign (Sep 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103518036
- GRCh38:
- Chr13:102865686
| BIVM-ERCC5, ERCC5 | | not provided, Xeroderma pigmentosum, group G | Benign (Sep 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103528184
- GRCh38:
- Chr13:102875834
| BIVM-ERCC5, ERCC5 | | not provided, Xeroderma pigmentosum, group G | Conflicting interpretations of pathogenicity (May 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103514628
- GRCh38:
- Chr13:102862278
| BIVM-ERCC5, ERCC5 | A377fs, A831fs | Xeroderma pigmentosum, group G | Uncertain significance (Dec 5, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103527869
- GRCh38:
- Chr13:102875519
| BIVM-ERCC5, ERCC5 | | not provided, Xeroderma pigmentosum, group G | Benign/Likely benign (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103519015
- GRCh38:
- Chr13:102866665
| BIVM-ERCC5, ERCC5, LOC126861834 | Q785*, Q1239* | Xeroderma pigmentosum, group G | Likely pathogenic (Feb 20, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103514459
- GRCh38:
- Chr13:102862109
| ERCC5, BIVM-ERCC5 | | not provided, Xeroderma pigmentosum, group G | Benign/Likely benign (Oct 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103528342
- GRCh38:
- Chr13:102875992
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G, not provided | Benign (Feb 24, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103528337
- GRCh38:
- Chr13:102875987
| ERCC5, BIVM-ERCC5 | | Xeroderma pigmentosum, group G, not provided | Benign (Nov 11, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103528224
- GRCh38:
- Chr13:102875874
| BIVM-ERCC5, ERCC5 | R1178C, R1632C | Xeroderma pigmentosum, group G | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103528184
- GRCh38:
- Chr13:102875834
| BIVM-ERCC5, ERCC5 | | not provided, Xeroderma pigmentosum, group G | Conflicting interpretations of pathogenicity (Jul 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103528178
- GRCh38:
- Chr13:102875828
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G, Hereditary cancer-predisposing syndrome, not provided
| Conflicting interpretations of pathogenicity (Dec 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103528120
- GRCh38:
- Chr13:102875770
| BIVM-ERCC5, ERCC5 | A1143V, A1597V | not provided, Xeroderma pigmentosum, group G | Conflicting interpretations of pathogenicity (Feb 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103528104
- GRCh38:
- Chr13:102875754
| BIVM-ERCC5, ERCC5 | V1138M, V1592M | Hereditary cancer-predisposing syndrome, Xeroderma pigmentosum, group G | Uncertain significance (Dec 28, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103527695
- GRCh38:
- Chr13:102875345
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G, not provided | Conflicting interpretations of pathogenicity (Jun 13, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103527643
- GRCh38:
- Chr13:102875293
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103524713
- GRCh38:
- Chr13:102872363
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103524687
- GRCh38:
- Chr13:102872337
| BIVM-ERCC5, ERCC5 | V940M, V1394M | Xeroderma pigmentosum, group G, Cerebrooculofacioskeletal syndrome 3, not provided, Xeroderma pigmentosum, group G, Inborn genetic diseases, Hereditary cancer-predisposing syndrome, not specified | Conflicting interpretations of pathogenicity (Sep 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103524647
- GRCh38:
- Chr13:102872297
| BIVM-ERCC5, ERCC5 | | not provided, Xeroderma pigmentosum, group G, Hereditary cancer-predisposing syndrome
| Benign/Likely benign (Oct 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103520529
- GRCh38:
- Chr13:102868179
| BIVM-ERCC5, ERCC5 | P867L, P1321L | Cerebrooculofacioskeletal syndrome 3, Xeroderma pigmentosum, group G | Uncertain significance (Feb 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103520453
- GRCh38:
- Chr13:102868103
| BIVM-ERCC5, ERCC5 | | Hereditary cancer-predisposing syndrome, Xeroderma pigmentosum, group G, not provided
| Conflicting interpretations of pathogenicity (Jan 16, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103518967
- GRCh38:
- Chr13:102866617
| BIVM-ERCC5, ERCC5, LOC126861834 | | Xeroderma pigmentosum, group G | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103518707
- GRCh38:
- Chr13:102866357
| BIVM-ERCC5, ERCC5, LOC126861834 | | Xeroderma pigmentosum, group G | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103518680
- GRCh38:
- Chr13:102866330
| LOC126861834, BIVM-ERCC5, ERCC5 | Q756H, Q1210H | Xeroderma pigmentosum, group G | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103518620
- GRCh38:
- Chr13:102866270
| BIVM-ERCC5, ERCC5, LOC126861834 | L736F, L1190F | Xeroderma pigmentosum, group G | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103518252
- GRCh38:
- Chr13:102865902
| BIVM-ERCC5, ERCC5, LOC126861834 | | Xeroderma pigmentosum, group G, not provided | Conflicting interpretations of pathogenicity (Sep 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103518162
- GRCh38:
- Chr13:102865812
| BIVM-ERCC5, ERCC5, LOC126861834 | | not provided, Xeroderma pigmentosum, group G | Benign (Sep 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103515425
- GRCh38:
- Chr13:102863075
| BIVM-ERCC5, ERCC5 | | not provided, Hereditary cancer-predisposing syndrome, Xeroderma pigmentosum, group G
| Benign/Likely benign (Oct 6, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103515416
- GRCh38:
- Chr13:102863066
| BIVM-ERCC5, ERCC5 | | not provided, Xeroderma pigmentosum, group G | Conflicting interpretations of pathogenicity (Dec 31, 2019) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103515140
- GRCh38:
- Chr13:102862790
| BIVM-ERCC5, ERCC5 | | not provided, Xeroderma pigmentosum, group G, Hereditary cancer-predisposing syndrome
| Conflicting interpretations of pathogenicity (Mar 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103515062
- GRCh38:
- Chr13:102862712
| BIVM-ERCC5, ERCC5 | | not provided, Xeroderma pigmentosum, group G, Hereditary cancer-predisposing syndrome
| Benign/Likely benign (Oct 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103514959
- GRCh38:
- Chr13:102862609
| BIVM-ERCC5, ERCC5 | P487L, P941L | Cerebrooculofacioskeletal syndrome 3, not provided, Xeroderma pigmentosum, group G
| Uncertain significance (Mar 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103514786
- GRCh38:
- Chr13:102862436
| BIVM-ERCC5, ERCC5 | | Hereditary cancer-predisposing syndrome, not provided, Xeroderma pigmentosum, group G
| Conflicting interpretations of pathogenicity (Sep 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103514731
- GRCh38:
- Chr13:102862381
| BIVM-ERCC5, ERCC5 | T411M, T865M | Xeroderma pigmentosum, group G, Inborn genetic diseases, not provided
| Conflicting interpretations of pathogenicity (Nov 15, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103514630
- GRCh38:
- Chr13:102862280
| BIVM-ERCC5, ERCC5 | | not provided, Xeroderma pigmentosum, group G | Conflicting interpretations of pathogenicity (Aug 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103514609
- GRCh38:
- Chr13:102862259
| ERCC5, BIVM-ERCC5 | | Xeroderma pigmentosum, group G, Hereditary cancer-predisposing syndrome, not provided
| Conflicting interpretations of pathogenicity (Aug 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103513923
- GRCh38:
- Chr13:102861573
| BIVM-ERCC5, ERCC5 | I247V, I701V | Hereditary cancer-predisposing syndrome, not specified, Xeroderma pigmentosum, group G, not provided | Uncertain significance (Jul 21, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103510766
- GRCh38:
- Chr13:102858416
| BIVM-ERCC5, ERCC5 | E224Q, E678Q | Xeroderma pigmentosum, group G | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103510765
- GRCh38:
- Chr13:102858415
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103510638
- GRCh38:
- Chr13:102858288
| BIVM-ERCC5, ERCC5 | H181R, H635R | Xeroderma pigmentosum, group G, Inborn genetic diseases, not provided
| Uncertain significance (Jun 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103506699
- GRCh38:
- Chr13:102854349
| BIVM-ERCC5, ERCC5 | P148S, P602S | not provided, Cerebrooculofacioskeletal syndrome 3, Xeroderma pigmentosum, group G, Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Oct 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103506686
- GRCh38:
- Chr13:102854336
| ERCC5, BIVM-ERCC5 | | Xeroderma pigmentosum, group G, not provided | Benign (Sep 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103504506
- GRCh38:
- Chr13:102852156
| BIVM-ERCC5, ERCC5 | R43W, R497W | Hereditary cancer-predisposing syndrome, Xeroderma pigmentosum, group G | Uncertain significance (Mar 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103498545
- GRCh38:
- Chr13:102846195
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G, not provided | Benign (Nov 11, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103498543
- GRCh38:
- Chr13:102846193
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G, not provided | Benign (Apr 3, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103498491
- GRCh38:
- Chr13:102846141
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103498461
- GRCh38:
- Chr13:102846111
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103498417
- GRCh38:
- Chr13:102846067
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G, not provided | Benign/Likely benign (Jun 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103498376
- GRCh38:
- Chr13:102846026
| BIVM-ERCC5, ERCC5 | | Xeroderma pigmentosum, group G | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr13:103498375
- GRCh38:
- Chr13:102846025
| BIVM-ERCC5, ERCC5 | | not provided, Xeroderma pigmentosum, group G | Benign (Nov 11, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103498198
- GRCh38:
- Chr13:102845848
| ERCC5, BIVM-ERCC5 | | not provided, Xeroderma pigmentosum, group G | Benign (Nov 11, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103514444
- GRCh38:
- Chr13:102862094
| ERCC5, BIVM-ERCC5 | | Hereditary cancer-predisposing syndrome, not specified, not provided, Xeroderma pigmentosum, group G | Benign/Likely benign (Oct 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103524762
- GRCh38:
- Chr13:102872412
| BIVM-ERCC5, ERCC5 | | Cerebrooculofacioskeletal syndrome 3, not specified, Xeroderma pigmentosum, group G, not provided | Benign (Oct 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103504650
- GRCh38:
- Chr13:102852300
| BIVM-ERCC5, ERCC5 | | not specified, not provided, Xeroderma pigmentosum, group G
| Benign (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103514939
- GRCh38:
- Chr13:102862589
| BIVM-ERCC5, ERCC5 | | not specified, not provided, Xeroderma pigmentosum, group G
| Benign (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr13:103527930
- GRCh38:
- Chr13:102875580
| BIVM-ERCC5, ERCC5 | R1080*, G1080*, G1534* | not specified, Xeroderma pigmentosum, group G | Conflicting interpretations of pathogenicity (Jul 7, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr13:103515288
- GRCh38:
- Chr13:102862938
| BIVM-ERCC5, ERCC5 | V597L, V1051L | Cerebrooculofacioskeletal syndrome 3, Hereditary cancer-predisposing syndrome, not provided, Xeroderma pigmentosum, group G | Conflicting interpretations of pathogenicity (Oct 1, 2022) | criteria provided, conflicting interpretations |